Dysembryoplastic neuroepithelial tumor (DNET) is a benign brain tumor associated with
intractable drug-resistant epilepsy. In order to identify underlying genetic alterations and …

Background In response to the recent serogroup W invasive meningococcal disease (IMD-W)
epidemic in the Netherlands, meningococcal serogroup C (MenC) conjugate vaccination …

… Author links open overlay panel Milou Ohm a 1 , Joeri W. van Straalen b 1 , Marieke Zijlstra
c , Gerrie de Joode-Smink b , Anne Jasmijn Sellies b , Joost F. Swart b d , Sebastiaan J. …

Neisseria meningitidis is often asymptomatically carried in the nasopharynx but may cause
invasive meningococcal disease, leading to morbidity and mortality. Meningococcal …

Background Meningococcal serogroup C (MenC) vaccination was introduced for 14-month-olds
in the Netherlands in 2002, alongside a mass campaign for 1–18 year-olds. Due to an …

Background Immune responses to pediatric vaccinations have been reported to differ
according to sex. Such sex-differential responses may become more pronounced during …

Background Complement-mediated killing is critical in the defense against meningococci.
During a recent outbreak of invasive meningococcal serogroup W disease (IMD-W) in the …

Background: A rise in serogroup C invasive meningococcal disease (IMD-C) led to introduction
of MenC vaccination in 2002 in the Netherlands at 14 months of age, accompanied by a …

Background Immunization with meningococcal ACWY conjugate vaccine induces protective
antibodies against invasive meningococcal disease (IMD) caused by serogroups A, C, W …

Background: Dysembryoplastic neuroepithelial tumors (DNETs) are benign developmental
brain tumors associated with intractable, drug-resistant epilepsy. Distinguishing this entity …